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of stem cell transplantation (SCT) are in an extremely
vulnerable position due to the risks related to their disease
and its treatment (Serna et al., 2003). The treatment related
risks (infection, GVHD, organ toxicity) could be life threat-
ening or have high morbidity. Patient understanding of the
risks and uncertain outcomes before the treatment begins is
not conﬁrmed by the limited research or evidence available.
Distressingly little is known about the experience of
patients from ethnically diverse backgrounds who undergo
SCT. Purpose The purpose of this pilot study is to describe
the experience of African-American, Latino and Caucasian
SCT patient before, during and after stem cell trans-
plantation in order to examine their expression of uncer-
tainty and risk acknowledgment. Theoretical Framework
Uncertainty, a mid-range nursing theory and framework for
this study, is deﬁned as the inability to determine the
meaning of illness-related events, occurring when the
decision maker is unable to assign deﬁnite value to objects
or events, or is unable to predict outcomes accurately
(Mishel, 1988). The nature of the disease of cancer and SCT
treatment with unpredictable outcomes makes this concept
especially relevant. Methods/Analysis Nine (three from each
ethnic group) patients’ previously conducted interviews
were analyzed using hermeneutic phenomenological design
to discover the informants’ expression of their experiences.
Uncertainty and risk perception at 5 time points (pre-
treatment to day 100) during SCT treatment was examined.
The purpose of hermeneutics is to clarify the meaning of
unfamiliar experiences and to explain human phenomena.
Hermeneutic methodology suggests meaning and signiﬁ-
cance have individual interpretation based on personal
variables and cultural inﬂuence. The goal of this analytical
process will be the development of a rich description of the
participant's experience before, during, and after the treat-
ment with SCT. Findings The ﬁndings will present data in
a manner that reﬂects the meaning of the texts, the cultural
context, and describes the essence of the participants’
experiences thereby assisting healthcare providers under-
stand this treatment from the patient's perspective. This
understanding inﬂuences the development of patient
education material and supportive measures to assist future
SCT patients.537
Chlorhexidine Gluconate Impregnated Waterless Bath
System for the Reduction of Blood Stream Infections in
the BMT Population
Robin McFarland Rosselet. Blood & Marrow Transplant, The
James Cancer Hospital & Solove Research Institute, Columbus,
OH
Objectives: The primary objectivewas to determinewhether
blood and marrow transplant (BMT) patients bathed daily
with chlorhexidine gluconate (CHG) waterless bath system
have lower incidence of skin ﬂora associated (i.e. Staphylo-
coccus epidermis, Staphylococcus aureus) central line associ-
ated blood stream infections (CLABSI) and total CLABSIs
compared to patients bathed with the standard CHG soap
and water method.
Background: Patients undergoing BMT are immunocom-
promised hosts whose leading cause of death during the
transplant process is infection. Multiple studies have pre-
sented solid evidence that hospital water systems and bath
basins are the source of serious waterborne nosocomial
infection and exposure comes from showering and bathing.
A number of studies in the medical intensive care unitshave shown a signiﬁcant reduction in hospital acquired
CLABSIs after implementing the use of CHG waterless bath
system.
Methods: This project was an innovative, evidence based
intervention to decrease CLABSI rates (5.2/1000 catheter
days) through the use of a CHG impregnated waterless
bath system for daily hygiene. It included (N¼281; 3451
catheter days) historical controls who showered using
CHG soap and water bathing during their admission for
BMT versus (N¼290; 3838 catheter days) patients bathed
with CHG waterless bath system. Data for both groups was
extracted from a BMT program database. Outcome
measures included incidence of total CLABSI and skin ﬂora
associated CLABSI.
Results: BMT patients bathed with CHG waterless bath
intervention had signiﬁcantly fewer CLABSI associated with
skin ﬂora (Staphylococcus epidermis & Staphylococcus aureus)
(P < .05). Overall CLABSI rate were reduced from 5.2/1000
catheter days to 4.1/1000 catheter days which did not reach
statistical signiﬁcant but showed an important downward
trend.
Conclusions: Daily bathing of patients with CHG waterless
bath system signiﬁcantly decreased CLABSI, associated with
skin ﬂora. It is an easy, time-efﬁcient, cost-effective inter-
vention to decrease these infections in patients undergoing
a BMT.538
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Background: Community-acquired respiratory virus (CRV)
infections are a threat to hematopoietic stem cell trans-
plant (HSCT) outpatients. High mortality rates have been
associated with CRV pneumonia. CRV is also responsible
for unscheduled re-admissions, lengthy treatments, and
increased medical costs. Graft versus host disease, immune
status, and conditioning regimens were not associated
with the development of CRV by the HSCT patient in
previous studies. In investigations of non-HSCT house-
holds, the presence of CRV infections and their spread were
correlated with the presence of secondary family
members. Therefore, the objectives of this study were to
determine if children or the number of contacts living in
the immediate household increase the risk of CRV acqui-
sition in HSCT outpatients.
Methods: A descriptive correlational design with a retro-
spective medical record review of adult outpatients who
received a HSCT between July1, 2006 and December 31, 2009
was performed. Respiratory viral cultures were followed for
24months after date of transplant. Age of children <18 years
and number of household members were obtained from the
pre-transplant assessment. Summary statistics were used to
describe sample characteristics. Binary logistic regression
was used to determine whether the number of household
member contacts or the number of children in each of three
age groups was a signiﬁcant predictor of CRV. Multivariate
linear regression was used to investigate predictors of the
number of CRV infections.
Results: The sample (N¼ 720) had a mean age (SD) of 51.8
(12.4); 54% were in the allogeneic (allo) group, 44% in the
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Across all patients, children ages 0-4 years (P¼ .01) and 5-12
years (P¼ .001) predicted CRV infection. The allo group had
the greatest incidence of CRV infection (16%), and were most
sensitive to the presence of young children. Total number of
household members was not a predictor of CRV. The mean
number of days to CRV infection for all groups was 283 days
post-transplant.
Conclusions: Households with children in the age groups
of 0-4 and 5-12 more than doubled the risk of an HSCT
patient acquiring a CRV infection. Further studies are
needed to test interventions designed to interrupt house-
hold transmission of CRV from children to the vulnerable
HSCT patient. Household contacts, especially children,
should be included in transplant teaching. As indicated by
the potentially high number of days between transplant
and CRV infection, re-education and continuing focus on
CRV prevention should be reinforced throughout the post-
transplant period.
*0-4 year age group P¼ .01
**5-12 year age group P¼ .001539
Loneliness in Transplant Caregivers: Exploration of
Related Factors
Leslie Wehrlen 1, Stephen D. Klagholz 2, Lara Mitra 3,
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Serving as a caregiver for someone undergoing intense
cancer treatments, such as allogeneic transplantation, has
beneﬁts but also carries unavoidable psychological and
emotional effects, which may include loneliness. Loneliness
is deﬁned as feeling isolated or alone when one desires
connections with others. Cross-sectional data were drawn
from hematopoietic stem cell transplant (HSCT) caregivers
(CG) (n¼21) and matched (age, gender, race/ethnicity) non-
caregiver controls (MC) (n¼20) to examine their level of
loneliness and related factors.
Methods: Adult HSCT CGs literate in English/Spanish, pre-
HSCT, completed the Health Promoting Lifestyle Proﬁle-II,
General Self Efﬁcacy scale, PROMIS short forms and UCLA
Loneliness scale.Results: CGs were primarily female (66.7%), 50.8 years old
(+ 11.9) and spouse of the HSCT recipient (52.4%). Thirteen
(61.9%) were sole CGs while 38.1% were members of a CG
‘network’. Adult patients were preparing for a reduced
intensity (61.9%), peripheral blood (95.2%) related donor
(85.7%) HSCT for lymphoma (28.6%) or leukemia (33.3%).
CG loneliness scores were signiﬁcantly higher (p¼0.022)
than MCs (20.86 + 5.7 vs. 17.0 + 4.6), with male CGs
signiﬁcantly higher than male MCs. Sole male CGs who
were spouses reported highest loneliness scores. Loneli-
ness was signiﬁcantly related (P < .05) to interpersonal
relations, spiritual growth and self-efﬁcacy, suggesting CGs
with well-established relationships, spiritual connections
and conﬁdence in their caregiving abilities were less
lonely.
Conclusion: Conﬁdence as a CG is critical for HSCT patient
recovery but also CG well-being. Assessing loneliness in
HSCT CGs may be of value especially in groups at risk for
loneliness. Future research should explore interventions
that modify health behaviors such as developing relation-
ships and enhancing self-efﬁcacy in CGs and HSCT
recipients.
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Introduction: The area-under-the curve (AUC) for busulfan
has been linked to clinical outcomes such as veno-occlusive
disease (VOD) and cancer relapse. The choice of body weight
(actual versus adjusted weight) to calculate the dose of
busulfan may be critical in attaining goal AUC based on
pharmacokinetic (PK) analysis, especially for overweight
patients.
Objective: Determine a correlation between weight chosen
for dosing of busulfan and outcomes.
Methods: An IRB-approved retrospective analysis was per-
formed on hematopoietic stem cell transplant (HSCT)
recipients who had received either Q6H IV busulfan with
cyclophosphamide (Bu/Cy) or once-daily IV busulfan with
ﬂudarabine (Flu/Bu) as conditioning regimens. All patients
underwent prospective monitoring of serum PKs at
a specialized therapeutic drug monitoring central laboratory.
Data was analyzed using Systat ver 13.
Results: Of the 31 patients with evaluable PK results, mean
age was 53 years; 48% were male; 77% were Caucasian and
58% had AML/MDS. GVHD prophylaxis consisted of tacroli-
mus/methotrexate in 58% and tacrolimus/mini-metho-
trexate in 42% of patients; 35% of the patients also received
anti-thymocyte globulin. With regards to conditioning
regimen, 58% received Flu/Bu (50% dosed on actual weight,
50% dosed on adjusted) and 42% received Bu/Cy (23% ¼
actual weight, 77% ¼ adjusted). Only two patients did not
require a dose adjustment based on AUC results. Overall,
